These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49 related articles for article (PubMed ID: 29162351)
21. Interplay between Cytoplasmic and Nuclear Androgen Receptor Splice Variants Mediates Castration Resistance. Zhan Y; Zhang G; Wang X; Qi Y; Bai S; Li D; Ma T; Sartor O; Flemington EK; Zhang H; Lee P; Dong Y Mol Cancer Res; 2017 Jan; 15(1):59-68. PubMed ID: 27671337 [TBL] [Abstract][Full Text] [Related]
22. Androgen Receptor Variant AR-V9 Is Coexpressed with AR-V7 in Prostate Cancer Metastases and Predicts Abiraterone Resistance. Kohli M; Ho Y; Hillman DW; Van Etten JL; Henzler C; Yang R; Sperger JM; Li Y; Tseng E; Hon T; Clark T; Tan W; Carlson RE; Wang L; Sicotte H; Thai H; Jimenez R; Huang H; Vedell PT; Eckloff BW; Quevedo JF; Pitot HC; Costello BA; Jen J; Wieben ED; Silverstein KAT; Lang JM; Wang L; Dehm SM Clin Cancer Res; 2017 Aug; 23(16):4704-4715. PubMed ID: 28473535 [No Abstract] [Full Text] [Related]
23. Calpain and AR-V7: Two potential therapeutic targets to overcome acquired docetaxel resistance in castration-resistant prostate cancer cells. Liu L; Lou N; Li X; Xu G; Ruan H; Xiao W; Qiu B; Bao L; Yuan C; Huang X; Wang K; Cao Q; Chen K; Yang H; Zhang X Oncol Rep; 2017 Jun; 37(6):3651-3659. PubMed ID: 28498452 [TBL] [Abstract][Full Text] [Related]
25. Re: ARv7 Represses Tumor-Suppressor Genes in Castration-Resistant Prostate Cancer. Atala A J Urol; 2019 Nov; 202(5):869-870. PubMed ID: 31365309 [No Abstract] [Full Text] [Related]
26. Predictive Significance of Androgen Receptor Splice Variant 7 in Patients With Metastatic Castration-Resistant Prostate Cancer: The PROPHECY Study. Dirix L J Clin Oncol; 2019 Aug; 37(24):2180-2181. PubMed ID: 31265358 [No Abstract] [Full Text] [Related]
27. Practical Polling for Prostate Cancer: AR-V7-based Treatment Selection. Lamb AD; Lawrence MG; Sandhu S Eur Urol; 2017 Jun; 71(6):883-885. PubMed ID: 28089303 [No Abstract] [Full Text] [Related]
28. The way towards understanding possible multiple functions of AR V7 in prostate cancer. Culig Z BJU Int; 2018 Aug; 122(2):169. PubMed ID: 30134059 [No Abstract] [Full Text] [Related]
29. AR-V7 biomarker testing for primary prostate cancer: The ongoing challenge of analytical validation and clinical qualification. Sowalsky AG; Sharp A; Trostel SY; de Bono JS; Plymate SR Cancer Treat Res Commun; 2021; 28():100218. PubMed ID: 33516656 [No Abstract] [Full Text] [Related]
30. Ailanthone: a new potential drug for castration-resistant prostate cancer. Peng S; Yi Z; Liu M Chin J Cancer; 2017 Mar; 36(1):25. PubMed ID: 28257652 [No Abstract] [Full Text] [Related]
31. Living Longer and Better with Advanced Prostate Cancer. Mukherji D; Omlin A; Pezaro C Eur Urol; 2020 Sep; 78(3):358-359. PubMed ID: 32553618 [No Abstract] [Full Text] [Related]